Indication of the Parent Protocol
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Remibrutinib | Novartis AG (NVS) |
Frequently asked questions
How many drugs are in development for Indication of the Parent Protocol?
BioSniper tracks 1 drug in development for Indication of the Parent Protocol across 1 company.
How many clinical trials target Indication of the Parent Protocol?
There are 1 clinical trial targeting Indication of the Parent Protocol tracked by BioSniper.
Deep-dive into Indication of the Parent Protocol
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis